This Article Full Text Full Text (PDF) All Versions of this Article: 29/6/610    most recent Author Manuscript (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Friedrich, N. Articles by Wallaschofski, H. Search for Related Content PubMed PubMed Citation Articles by Friedrich, N. Articles by Wallaschofski, H.

Reference Ranges for Serum Dehydroepiandrosterone Sulfate and Testosterone in Adult Men

NELE FRIEDRICH^*,

DIETER ROSSKOPF

ANTJE STEVELING

ALEXANDER KREBS

MATTHIAS NAUCK

HENRI WALLASCHOFSKI

From the ^* Institute for Community Medicine, the Department of Gastroenterology, Endocrinology, and Nutrition, the Institute of Pharmacology, and the Institute of Clinical Chemistry and Laboratory Medicine, Ernst Moritz Arndt University, Greifswald, Germany.

Correspondence to: Dr Nele Friedrich, Institute for Community Medicine, Ernst Moritz Arndt University, Walther Rathenau Str 48, D-17487 Greifswald, Germany (e-mail: nele.friedrich{at}uni-greifswald.de).

Dehydroepiandrosterone (DHEA) is the main adrenal androgen, which mostly exists in a sulfated version (DHEAS). Both DHEA and DHEAS are metabolic intermediates in the biosynthesis of the male sex hormone testosterone. In men, testosterone is involved in the regulation of fertility, libido, and muscle mass and is valuable for the assessment of gonadal, adrenal, and pituitary function and for the diagnosis of hypogonadism. The objective of the present study was to calculate age-specific reference ranges for serum DHEAS and serum testosterone using 1) linear regression and the mean ± 1.96 standard deviation concept and 2) quantile regression. From the cross-sectional Study of Health in Pomerania a total of 1078 men aged 20–79 years were included in the analyses. Serum DHEAS and testosterone levels were quantified using IMMULITE 2500 immunoassays. Linear and quantile regression were performed to calculate age-specific reference ranges. Both statistical methods generated different results: The reference ranges based on linear regression identified 17 men (1.6%) with DHEAS levels and 45 men (4.2%) with serum testosterone levels outside the reference range. Using quantile regression, 54 men (5.0%) and 50 men (4.6%) with serum DHEAS and testosterone levels outside the range were detected, respectively. The present study established age-specific reference ranges for serum DHEAS and testosterone levels for men. Quantile regression should be preferred to calculate reference ranges; a better concordance with original data is possible because no distribution assumption is required and the robustness against outliers is given.

     Key words: Total testosterone, dehydroepiandrosterone sulfate, reference ranges, quantile regression, Study of Health in Pomerania (SHIP)

This article has been cited by other articles:

				R. Haring, A. Hannemann, U. John, D. Radke, M. Nauck, H. Wallaschofski, L. Owen, J. Adaway, B. G. Keevil, and G. Brabant Age-Specific Reference Ranges for Serum Testosterone and Androstenedione Concentrations in Women Measured by Liquid Chromatography-Tandem Mass Spectrometry J. Clin. Endocrinol. Metab., February 1, 2012; 97(2): 408 - 415. [Abstract] [Full Text] [PDF]

				K. Empen, R. Lorbeer, M. Dorr, R. Haring, M. Nauck, S. Glaser, A. Krebs, T. Reffelmann, R. Ewert, H. Volzke, et al. Association of Testosterone Levels With Endothelial Function in Men: Results From a Population-Based Study Arterioscler Thromb Vasc Biol, February 1, 2012; 32(2): 481 - 486. [Abstract] [Full Text] [PDF]

				H. Volzke, D. Alte, C. O. Schmidt, D. Radke, R. Lorbeer, N. Friedrich, N. Aumann, K. Lau, M. Piontek, G. Born, et al. Cohort Profile: The Study of Health in Pomerania Int. J. Epidemiol., April 1, 2011; 40(2): 294 - 307. [Full Text] [PDF]

				J. J. Naghi, K. J. Philip, D. DiLibero, R. Willix, and E. R. Schwarz Review: Testosterone Therapy: Treatment of Metabolic Disturbances in Heart Failure Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2011; 16(1): 14 - 23. [Abstract] [PDF]

				R. Haring, H. Volzke, S. B. Felix, S. Schipf, M. Dorr, D. Rosskopf, M. Nauck, C. Schofl, and H. Wallaschofski Prediction of Metabolic Syndrome by Low Serum Testosterone Levels in Men: Results From the Study of Health in Pomerania Diabetes, September 1, 2009; 58(9): 2027 - 2031. [Abstract] [Full Text] [PDF]